THE BEST SIDE OF SEMAGLUTUDE WEEKS 13-16 BUNDLE

The demo achieved the two its Most important endpoints, with semaglutide two.4 mg demonstrating statistically significant and exceptional enhancements in liver fibrosis with no worsening of steatohepatitis, and resolution of steatohepatitis without any worsening of liver fibrosis in people with MASH when compared with placebo.oneThese highlights do